Nanoparticle Albumin-Bound (Nab) Paclitaxel/Cyclophosphamide in Early-Stage Breast Cancer

NCT00629499 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

63

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: nab paclitaxel
DRUG: Cyclophosphamide
DRUG: Trastuzumab

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]